| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/26/2012 | WO2012054008A2 Methods and compositions comprising tau oligomers |
| 04/26/2012 | WO2012053828A2 Human interleukin-1 receptor antagonist - hybrid fc fusion protein |
| 04/26/2012 | WO2012053823A2 Fusion protein having factor ix activity |
| 04/26/2012 | WO2011160026A3 Clostridium taeniosporum spores and spore appendages as surface display hosts, drug delivery devices, and nanobiotechnological structures |
| 04/26/2012 | US20120101256 Multispecific peptides |
| 04/26/2012 | US20120100166 Ang-2 Binding Complexes and Uses Thereof |
| 04/26/2012 | US20120100159 Anti-tat226 antibodies and immunoconjugates |
| 04/26/2012 | US20120100158 Anti ceacam1 antibodies and methods of using same |
| 04/26/2012 | US20120100141 Drug fusions and conjugates |
| 04/26/2012 | US20120100139 CD86 Antagonist Multi-Target Binding Proteins |
| 04/26/2012 | US20120100130 Novel Receptor Hetero-Dimers/-Oligomers |
| 04/26/2012 | US20120100099 Fusion proteins having mutated immunoglobulin hinge region |
| 04/26/2012 | US20120100074 Humanized antibodies against light and uses thereof |
| 04/26/2012 | CA2815279A1 Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
| 04/26/2012 | CA2814947A1 Fusion protein with factor ix activity |
| 04/25/2012 | EP2444414A1 Peptidic antigen that induces antibody recognizing three-dimensional structure of hiv and method for synthesizing same |
| 04/25/2012 | EP2444409A2 Compositions and methods for the treatment of immune related diseases |
| 04/25/2012 | EP2443155A1 Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularih 1 (mtm1) polypeptides |
| 04/25/2012 | EP1789452B1 Relaxin-chimeric polypeptides and their preparation and use |
| 04/25/2012 | EP1682581B1 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 04/25/2012 | EP0773997B2 Htk ligand |
| 04/25/2012 | CN102428175A Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
| 04/25/2012 | CN102428105A Antibodies containing therapeutic tpo/epo mimetic peptides |
| 04/25/2012 | CN102428104A 新型双重靶定抗体及其用途 The new dual-targeting antibodies and their use |
| 04/25/2012 | CN101962412B Recombinant TAT-XIAP fusion protein |
| 04/25/2012 | CN101830985B 肠出血性大肠杆菌O157:H7Tir与Tccp的重组蛋白 EHEC O157: H7Tir and Tccp recombinant protein |
| 04/25/2012 | CN101724027B 蛋白质三聚体化模序及其应用 Protein trimerization motif and its application |
| 04/25/2012 | CN101717450B 抗菌肽lfb-me及其制备方法 Antimicrobial peptides lfb-me and its preparation method |
| 04/25/2012 | CN101392027B 一种治疗阿尔茨海默病的融合蛋白及其制备方法 A fusion protein of Alzheimer's disease and its preparation method of treatment |
| 04/25/2012 | CN101353663B 一种抗i型糖尿病融合蛋白及其制备方法 An anti-i fusion protein of Diabetes and its preparation method |
| 04/24/2012 | US8163889 Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| 04/24/2012 | CA2583722C Nematode resistant transgenic plants |
| 04/19/2012 | WO2012051247A2 Egfr-based peptides |
| 04/19/2012 | WO2012050921A2 Nd2 peptides and methods of treating neurological disease |
| 04/19/2012 | WO2012050919A2 Chimeric spider silk and uses thereof |
| 04/19/2012 | WO2012050714A2 Cartilage oligomeric matrix protein (comp)-growth factor complexes and uses thereof |
| 04/19/2012 | WO2012050402A2 Cell-permeable recombinant parkin protein and a pharmaceutical composition for treating degenerative brain diseases containing the same |
| 04/19/2012 | WO2012050374A2 Immunotherapy for solid tumors |
| 04/19/2012 | WO2012049328A1 Generation of multifunctional and multivalent polypeptide complexes with collagen xviii trimerization domain |
| 04/19/2012 | WO2012048653A1 Long-life interferon fusion protein and use thereof |
| 04/19/2012 | WO2012048430A1 Affinity-conjugated nucleoprotein-papaya mosaic virus-like particles and uses thereof |
| 04/19/2012 | WO2011152694A3 Fusion protein having factor vii activity |
| 04/19/2012 | WO2011136506A3 Method for producing recombinant complex antigens using nanoparticles of human rotavirus |
| 04/19/2012 | US20120095444 Polynucleotides encoding a human trim-cyp fusion polypeptide, compositions thereof, and methods of using same |
| 04/19/2012 | US20120095188 Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy |
| 04/19/2012 | US20120094909 Fibronectin based scaffold domain proteins that bind to pcsk9 |
| 04/19/2012 | US20120094873 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 04/19/2012 | US20120094356 In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasng in vivo half-life using same |
| 04/19/2012 | US20120093873 Molecular Interactions in Hematopoietic Cells |
| 04/19/2012 | US20120093858 Tat-Based Tolerogen Compositions and Methods for Making and Using Same |
| 04/19/2012 | US20120093847 Recombinant rsv vaccines |
| 04/19/2012 | US20120093840 Targeted delivery of factor viii proteins to platelets |
| 04/19/2012 | US20120093821 Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines |
| 04/19/2012 | CA2814670A1 Egfr-based peptides |
| 04/19/2012 | CA2812948A1 Nd2 peptides and methods of treating neurological disease |
| 04/19/2012 | CA2812791A1 Chimeric spider silk and uses thereof |
| 04/18/2012 | EP2441776A1 Generation of multifunctional and multivalent polypeptide complexes with collagen XVIII trimerization domain |
| 04/18/2012 | EP2440582A2 Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use |
| 04/18/2012 | EP2440581A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system |
| 04/18/2012 | CN101524526B LSECtin的一种新用途 A new use LSECtin |
| 04/18/2012 | CN101104641B 作为猪生殖和呼吸道征候群疫苗的prrs病毒的融合蛋白 As porcine reproductive and respiratory syndrome virus vaccine prrs fusion proteins |
| 04/17/2012 | US8158767 Polypeptides and methods for making the same |
| 04/17/2012 | US8158132 used to control the interaction of particular cell types with their external environment; for chronic pain; reduced side effects, long-lasting actions that do not require frequent injections or long-term catheterization; does not lead to tolerance and associated dependence |
| 04/17/2012 | US8158130 Method for the preparation of virus-like particles (VLPS) comprising heterologous multiple membrane spanning proteins |
| 04/17/2012 | CA2497982C Peptides and related molecules that modulate nerve growth factor activity |
| 04/17/2012 | CA2431600C Molecules with extended half-lives, compositions and uses thereof |
| 04/17/2012 | CA2410526C Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 04/17/2012 | CA2372181C Adjuvant combination formulations |
| 04/17/2012 | CA2347928C Cell surface molecule-induced macrophage activation |
| 04/17/2012 | CA2225378C Cytokine that induces apoptosis |
| 04/17/2012 | CA2202090C Papilloma virus-like particles, fusion proteins as well as processes for their production |
| 04/13/2012 | CA2752372A1 Method for treating diabetes |
| 04/12/2012 | WO2011162492A3 Fusion protein comprising small heat shock protein, cage protein formed thereby, and novel use thereof |
| 04/12/2012 | WO2011153276A3 Stable, functional chimeric cellobiohydrolase class i enzymes |
| 04/12/2012 | US20120090043 Targets for retrovirus associated diseases |
| 04/12/2012 | US20120088722 Compositions and methods for inhibition of mmp:mmp-substrate interactions |
| 04/12/2012 | US20120088268 Recombinant production of peptides |
| 04/12/2012 | US20120087939 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection |
| 04/12/2012 | US20120087937 Novel compositions |
| 04/12/2012 | US20120087921 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer |
| 04/12/2012 | US20120087920 Fgf21 mutants and uses thereof |
| 04/12/2012 | CA2811364A1 Methods and compositions for inhibiting viral entry into cells |
| 04/11/2012 | EP2439275A1 Gene capable of increasing protein content in seed, and method for utilization thereof |
| 04/11/2012 | EP2438173A2 Biomaterials, compositions, and methods |
| 04/11/2012 | EP2438170A2 Soga polynucleotides and polypeptides and uses thereof |
| 04/11/2012 | EP2437767A1 Molecules with extended half-lives and uses thereof |
| 04/11/2012 | EP1282646B1 Human monoclonal antibodies to dendritic cells |
| 04/11/2012 | EP0931162B1 Production of a multimeric protein by cell fusion method |
| 04/11/2012 | CN102414218A Tag peptide having protease recognition sequence and utilization of same |
| 04/11/2012 | CN102413837A 预防再激活的结核病tb疫苗 Tb prevent reactivation of tuberculosis vaccine |
| 04/11/2012 | CN102408485A 血小板生成素模拟肽二联体与人血清白蛋白的融合蛋白及其制备方法和应用 Human serum albumin fusion thrombopoietin mimetic peptide two conjoined protein and its preparation method and application |
| 04/11/2012 | CN102408484A 具有wnk激酶抑制作用的重组穿膜肽及其应用 Recombinant kinase inhibition has wnk penetrating peptide and its application |
| 04/11/2012 | CN102408470A Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation |
| 04/11/2012 | CN102408467A 真空干燥蛋白的方法、制得的蛋白产品和试剂盒 The method of vacuum drying the protein, the resulting protein products and kits |
| 04/11/2012 | CN102406929A 一种共表达分子佐剂加强型二价口蹄疫蛋白工程疫苗 A co-expression of molecular adjuvant enhanced protein engineering bivalent FMD vaccine |
| 04/11/2012 | CN101121751B Ptd-酪氨酸羟化酶催化区域融合蛋白及其应用 Ptd- tyrosine hydroxylase catalytic domain fusion protein and its application |
| 04/10/2012 | US8153774 Human T1R2 taste receptor nucleic acids and cells containing these nucleic acids |
| 04/10/2012 | US8153386 Human T2R64 taste receptor and related assays for identifying human bitter taste modulators |
| 04/10/2012 | CA2438921C Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 04/10/2012 | CA2412035C Hcv antigen/antibody combination assay |